Kaken Pharmaceutical Co., Ltd. (4521.T) JPX
Currency In JPY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In JPY
| Market Cap | 156.95B |
| Enterprise Value | 116.09B |
| P/E Ratio | 15.77 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 1.67 |
| Price/Book Ratio | 0.94 |
| Enterprise/Revenue | 1.09 |
| Enterprise/EBITDA | 6.31 |
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | 0.11 |
| Operating Margin | 0.1 |
| Return On Assets | 0.05 |
| Return On Equity | 0.06 |
| Revenue | 76.87B |
| Revenue/Share | 2,283.45 |
| Gross Profit | 39.24B |
| EBITDA | 5.68B |
| Net Income | 2.14B |
| Diluted EPS | 56.55 |
| Total Cash | 59.51B |
| Total Cash/Share | 1,571.58 |
| Total Debt | 3.85B |
| Total Debt/Equity | 0.03 |
| Current Ratio | 4.17 |
| Book Value Per Share | 4,046.58 |
| 52-Week Change | 6.42 |
| 52-Week High | 4,445 |
| 52-Week Low | 3,570 |
| Moving Average 50 Days | 3,859.3 |
| Moving Average 200 Days | 3,997.83 |
| Average Volume | 121,113 |
| Shares Outstanding | 37.87M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 190 |
| Trailing Annual Dividend Yield | 4.99 |
| Payout Ratio | 0 |
| Last Split Factor | 1:2 |
| Last Split Date | September 28, 2015 |